Cerus (CERS) Restructuring Costs (2010)

Cerus' (CERS) quarterly Restructuring Costs came in at -$182000.0 in Q4 2010, up 9.45% quarter-over-quarter from -$201000.0 in Q3 2010.

Cerus (CERS) Restructuring Costs (2010) Analysis & Trends

Cerus has disclosed Restructuring Costs across 1 years of filings, most recently posting -$182000.0 for Q4 2010.

Restructuring Costs for Q4 2010 came in at -$182000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2011 was -$182000.0 (changed N/A YoY), and the FY2009 annual result was $841000.0, changed N/A from the prior year.
Restructuring Costs came in at -$182000.0 for Q4 2010 at Cerus, up from -$201000.0 in the prior quarter.
In the past five years, Restructuring Costs ranged from a high of $132000.0 in Q2 2010 to a low of -$201000.0 in Q3 2010.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	152.92 Bn	146.27 Bn	6.27 Bn
2	Stryker	119.50 Bn	116.62 Bn	3.81 Bn
3	Medtronic	102.71 Bn	94.54 Bn	5.76 Bn
4	Boston Scientific	69.72 Bn	68.51 Bn	3.61 Bn
5	Edwards Lifesciences	49.24 Bn	45.57 Bn	1.29 Bn
6	GE HealthCare Technologies	29.74 Bn	27.67 Bn	1.98 Bn
7	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn
8	Dexcom	28.96 Bn	27.84 Bn	750.30 Mn
9	Steris	20.31 Bn	19.88 Bn	697.10 Mn
10	Cerus	496.03 Mn	416.34 Mn	27.89 Mn

Download Data